首页> 外国专利> Screening method of the anti-influenza drug and crystallization with the RNA polymerase expression system built from influenza virus

Screening method of the anti-influenza drug and crystallization with the RNA polymerase expression system built from influenza virus

机译:用流感病毒构建的RNA聚合酶表达系统筛选抗流感药物并结晶

摘要

Allowing overexpressed the RNA polymerase of influenza virus, to crystallize the RNA polymerase of influenza virus, and the present invention is effective for anti-influenza drugs that target proteins that are highly conserved among species of influenza virus and an object thereof is to provide a screening method for a substance that can be a component. The present invention includes a polypeptide comprising the amino acid sequence 1-81 of the RNA polymerase PB1 subunit polypeptide comprising the amino acid sequence 239-716 of the RNA polymerase PA subunit of influenza A / PUERTO RICO / 8/1934 H1N1 type complexes including, as well, in the presence of the candidate substance, comprising the step of selecting an agent that inhibits the interaction constitutes the RNA polymerase of influenza virus and α-subunit of β-subunit 1, the active ingredient of the anti-influenza drug I provides a screening method for a substance that may be.
机译:通过使流感病毒的RNA聚合酶过表达,使流感病毒的RNA聚合酶结晶化,本发明对于针对以流感病毒的种间高度保守的蛋白质为目标的抗流感药是有效的,其目的在于提供筛选方法。一种可以作为一种成分的物质的方法。本发明包括一种多肽,其包含RNA聚合酶PB1亚基的氨基酸序列1-81的多肽,所述多肽包含流感A / PUERTO RICO / 8/1934 H1N1型复合物的RNA聚合酶PA亚基的氨基酸序列239-716。同样,在候选物质存在下,包括选择抑制相互作用的试剂的步骤,该试剂构成流感病毒的RNA聚合酶和β-亚基1的α-亚基,抗流感药物I的活性成分提供一种可能的物质的筛选方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号